By Giorgi Dvalishvili ( September 10, 2026, 15:06 GMT | Insight) -- This week, the Unified Patent Court granted Abbott Diabetes Care a preliminary injunction, blocking SiBionics’ GS3-R glucose monitor across all 18 UPC states. Other rulings sharpened UPC rules on evidence preservation, staff questioning and third-party access to filings in pending appeals.This week, the Unified Patent Court granted med-tech company Abbott Diabetes Care’s injunction covering all 18 member states, while several other decisions focused on procedural issues....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.